19 Nov 2023
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
Session comprising selected PCR London Valves 2023 Late-Breaking Trial submissions
Anchorperson:
J. Granada
Spokesperson:
A. Petronio
Summary
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world clinical outcomes for tricuspid edge-to-edge repair: Two-year results from the bRIGHT study
